If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,908.00    -142.00 (-2.81%)
Bid:
4,914.00
Ask:
4,918.00
Spread: 4.00 (0.081%)
Market Cap: £17.89b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

19 Mar 2020 15:39

RNS Number : 8563G
Coca-Cola HBC AG
19 March 2020
 

FOR IMMEDIATE RELEASE

19 March 2020

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that on 17 March 2020, a deferred bonus award was granted to the Chief Executive Officer over shares of CHF 6.70 in the Company relating to a performance related annual bonus for 2019 under the terms of the Company's Management Incentive Plan (the "Deferred Shares"):

 PDMR

Position

Number of Deferred Shares granted

ZORAN BOGDANOVIC

CEO

16,007

 

The Notification of Dealing Form can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

ZORAN BOGDANOVIC

 

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF EXECUTIVE OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

SHARES

 

 

CH0198251305

b)

 

Nature of the transaction

 

 

GRANT OF DEFERRED SHARES UNDER THE MANAGEMENT INCENTIVE PLAN. THE NUMBER OF DEFERRED SHARES GRANTED IS EQUIVALENT TO 50 PER CENT OF THE ANNUAL BONUS AWARDED TO THE CHIEF EXECUTIVE OFFICER FOR THE 2019

FINANCIAL YEAR, CALCULATED ON THE BASIS OF THE CLOSING PRICE FOR THE DEFERRED SHARES ON THE DATE OF GRANT. THE DEFERRED SHARES WILL HAVE A VESTING PERIOD OF THREE YEARS FROM 31 DECEMBER 2019.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

14.94 GBP

16,007

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

14.94 GBP

16,007

239,144.58 GBP

e)

 

Date of the transaction

 

2020-03-17

f)

 

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

This notification is made in accordance with the requirements of the EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 37

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKKCBNPBKDPND
Date   Source Headline
15th Jan 20197:03 amRNSTransaction in Own Shares
14th Jan 20192:26 pmRNSNotice of Results
14th Jan 20197:09 amRNSTransaction in Own Shares
11th Jan 20197:21 amRNSTransaction in Own Shares
10th Jan 20197:13 amRNSTransaction in Own Shares
7th Jan 20192:18 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 20199:35 amRNSIssue of equity and total voting rights
18th Dec 20181:58 pmRNSDirector/PDMR Shareholding
17th Dec 20187:27 amRNSTransaction in Own Shares
14th Dec 20187:14 amRNSTransaction in Own Shares
13th Dec 201811:37 amRNSHolding(s) in Company
13th Dec 20187:16 amRNSTransaction in Own Shares
12th Dec 20187:13 amRNSTransaction in Own Shares
11th Dec 20187:11 amRNSTransaction in Own Shares
10th Dec 20187:13 amRNSTransaction in Own Shares
7th Dec 20187:15 amRNSTransaction in Own Shares
6th Dec 20187:09 amRNSTransaction in Own Shares
5th Dec 20187:13 amRNSTransaction in Own Shares
4th Dec 20187:14 amRNSTransaction in Own Shares
3rd Dec 201812:44 pmRNSIssue of equity and total voting rights
3rd Dec 20187:19 amRNSCommencement of share purchase programme
19th Nov 20183:17 pmRNSDirector/PDMR Shareholding
19th Nov 201812:36 pmRNSDirector/PDMR Shareholding
8th Nov 20187:00 amRNSA QUARTER OF SOLID GROWTH
18th Oct 20182:36 pmRNSDirector/PDMR Shareholding
11th Oct 20181:35 pmRNSNotice of Results
19th Sep 201810:26 amRNSDirector/PDMR Shareholding
3rd Sep 201812:26 pmRNSIssue of equity and total voting rights
20th Aug 201811:45 amRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSSTRONG VOLUME GROWTH DELIVERS GOOD RESULTS
1st Aug 20189:48 amRNSIssue of equity and total voting rights
26th Jul 20182:25 pmRNSDirector/PDMR Shareholding
18th Jul 201811:44 amRNSDirector/PDMR Shareholding
5th Jul 20183:46 pmRNSNotice of Results
2nd Jul 201810:13 amRNSIssue of equity and total voting rights
18th Jun 20181:42 pmRNSDirector/PDMR Shareholding
11th Jun 20183:20 pmRNSComposition of the Committees of the BoD of CCHBC
11th Jun 20182:35 pmRNSResult of AGM
1st Jun 201810:05 amRNSIssue of equity and total voting rights
18th May 20181:06 pmRNSDirector/PDMR Shareholding
15th May 20181:11 pmRNSDirector/PDMR Shareholding
15th May 20181:01 pmRNSDirector/PDMR Shareholding
15th May 201812:44 pmRNSDirector/PDMR Shareholding
10th May 20187:00 amRNSCONTINUING TO DELIVER BALANCED REVENUE GROWTH
8th May 201810:01 amRNSNotice of AGM
8th May 20189:20 amRNSChange to Board and dividend dates
4th May 20181:31 pmRNSAthens Exchange trading date of ordinary shares
1st May 20189:52 amRNSBlock listing Interim Review
1st May 20189:42 amRNSIssue of equity and total voting rights
18th Apr 20182:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.